RARE DISEASES A–Z · LETTER C
Corticobasal Degeneration
Corticobasal degeneration is a rare brain disease in which tau protein damages the cerebral cortex and deep movement centres (the basal ganglia). Its signature is asymmetry: one side of the body — usually one arm — becomes stiff, clumsy, and increasingly disobedient, while the other side works almost normally at first.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
The earliest sign is usually one hand becoming clumsy and stiff: buttons, keys, and tools get difficult, and the limb may jerk (myoclonus) or adopt fixed postures (dystonia). Many people describe the limb as not feeling like theirs — the alien limb phenomenon, where the hand grasps or wanders semi-independently. Because the parietal cortex is involved, planning movements (apraxia) fails out of proportion to strength: the person knows what they want to do but cannot organise the action. Speech and language can falter, eye movements become effortful, and falls — often backwards — develop as balance fails. Thinking and memory are usually less affected at first than movement, the reverse of typical Alzheimer's disease.
How it works
There is no single confirmatory test in life. Diagnosis rests on the clinical pattern — asymmetric parkinsonism with apraxia, cortical sensory loss, myoclonus, or alien limb — supported by brain MRI showing shrinkage of the cortex and deep structures on the side opposite the worse limb. Specialised scans of dopamine systems and, increasingly, spinal fluid and blood biomarker tests help exclude Alzheimer's disease, which can produce an identical clinical picture (one reason doctors speak of 'corticobasal syndrome' for the presentation and reserve 'degeneration' for the tissue finding). Response to a trial of levodopa is typically poor, which itself is a clue. A movement-disorder specialist usually makes and revisits the diagnosis over time.
Day to day
No treatment slows the underlying degeneration, so care targets symptoms and safety. Levodopa and related Parkinson's medicines are usually tried but help modestly at best. Botulinum toxin injections can ease a painful, clenched dystonic hand. Physiotherapy works on balance, transfers, and fall prevention; occupational therapy adapts the home and teaches one-handed techniques, while weighted utensils and clothing fasteners restore some independence. Speech therapy supports communication and monitors swallowing, with diet changes if needed. Mood and apathy deserve active treatment. As the condition advances, the focus shifts to comfort, nutrition, and preventing complications such as pneumonia — the commonest cause of death — with palliative care teams involved early for support, not just at the end.
When to get help
Care is multidisciplinary: neurology, physiotherapy for gait and falls, occupational therapy for one-handed strategies and home safety, and speech therapy for speech and swallowing. Regular review catches treatable problems — low mood, pain from dystonia, constipation, and swallowing difficulty that can lead to chest infections. Driving usually has to stop, and early conversations about future care preferences help families plan. Seek prompt help for choking episodes, a chest infection, a fall with injury, or sudden worsening, which usually signals infection or another medical problem rather than the degeneration itself speeding up. Support organisations for atypical parkinsonism understand this rare condition's specific frustrations.
Common questions
Is corticobasal degeneration the same as corticobasal syndrome?
It is the commonest cause of the corticobasal syndrome — the clinical pattern of one-sided stiffness, clumsiness, and alien limb. But the same syndrome can be produced by Alzheimer's pathology or other protein diseases, which is why doctors distinguish the syndrome (what they see) from degeneration (the tissue diagnosis).
How is it different from Parkinson's disease?
No — the pattern is quite different. Parkinson's disease usually starts with tremor, responds well to levodopa for years, and affects both sides fairly early. Corticobasal degeneration is strikingly one-sided, causes limb apraxia and alien-limb behaviour, and responds poorly to Parkinson's medicines.
What is the 'alien limb' I have read about?
The alien limb phenomenon: the affected hand acts with a will of its own — grasping objects, interfering with the other hand, or drifting — because the brain's control and awareness of that limb are disrupted. It is distressing but understandable once explained, and occupational therapists can suggest strategies.
How fast does it progress?
Progression is usually measured in years rather than months, and many people live around six to eight years after symptoms begin, though the range is wide. Care focuses on safety, mobility, swallowing, and comfort as needs change.
More in Letter C
Related
Sources
- Corticobasal Degeneration (National Organization for Rare Disorders (NORD))
- Corticobasal Degeneration — Genetic and Rare Diseases Information Center (NIH GARD)
- Corticobasal Degeneration (NINDS)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Symptom treatment and therapy plans are individual; follow your movement-disorder team's advice.